Pilot Trial: Bioavailability Animal vs. Plant Protein Drink
Exploratory Pilot Trial Assessing the Immediate Impact of Animal-based and Plant-based Protein Drinks on Blood Parameters
1 other identifier
interventional
12
1 country
1
Brief Summary
A pilot study is being conducted to compare a new plant-based protein drink to commercially available animal-based protein drinks. The goal is to assess if the plant-based drink delivers amino acids to the bloodstream as effectively as the animal-based drinks, potentially offering a viable option for those on plant-based diets. The study will involve approximately 12 healthy adults aged 18-40. Each participant will try all three drinks (the new plant-based drink, a commercial animal-based drink, and another animal-based recipe) on separate days in a randomized order. Before and after (30, 60, and 90 minutes) consuming each drink, a small blood sample will be drawn to measure amino acid levels (leucine). By comparing the results, the investigators hope to determine if the plant-based drink can match the effectiveness of animal-based protein drinks in delivering essential nutrients. This research could contribute to the development of sustainable and nutritious plant-based protein alternatives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2024
CompletedFirst Submitted
Initial submission to the registry
June 13, 2024
CompletedFirst Posted
Study publicly available on registry
June 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedJune 21, 2024
June 1, 2024
20 days
June 13, 2024
June 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
leucine content in the blood
Assessment of leucine content in blood before and 30-60-90 min after consumption of drink
4 hours
Study Arms (3)
Animal-based A
ACTIVE COMPARATORA commercially available high protein drink, based on animal proteins (Fresubin Protein Energy)
Animal-based B
ACTIVE COMPARATORA homemade drink containing animal-based proteins, using a specific animal-based protein isolate mix.
Plant-based A
ACTIVE COMPARATORA homemade drink containing plant-based proteins, formulated to have the same macronutrient content as the animal-based drinks.
Interventions
The participants will drink on of three protein - rich drinks
Eligibility Criteria
You may qualify if:
- Gender: male and female
- Age: 18-40 years
- Signed written informed consent
You may not qualify if:
- Smoking history
- Cardiovascular diseases
- BMI \> 35 kg/m2
- Caffeine consumption \< 1 day before the study participation
- Allergies: Soy, Peas, Milk, Lactose, Fructose
- High intensity exercise \<2 days before study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ETH Zurichlead
Study Sites (1)
SLA - ETH Zurich
Schwerzenbach, Canton of Zurich, 8603, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Gommaar D'Hulst, PhD
ETH Zurich
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2024
First Posted
June 18, 2024
Study Start
June 8, 2024
Primary Completion
June 28, 2024
Study Completion
August 30, 2024
Last Updated
June 21, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share